Literature DB >> 19433304

Hepatic stellate cell: a star cell in the liver.

Luigi Atzori1, Giuseppe Poli, Andrea Perra.   

Abstract

Hepatic stellate cells represent a highly versatile cytotype that plays a significant role in liver development and differentiation, regeneration, xenobiotic response, immunoregulation, control of hepatic blood flow and inflammatory reactions. Because of the wide panel of molecular intermediates they may produce and secrete, particularly after their sustained activation in a disease state, hepatic stellate cells are definitely involved in the pathogenesis of various liver pathologies, besides the well know key role in fibrosis and extracellular matrix remodelling. In particular, they can actively contribute to the progression of hepatitis and steatohepatitis of different aetiology, and of liver carcinogenesis.

Entities:  

Mesh:

Year:  2009        PMID: 19433304     DOI: 10.1016/j.biocel.2009.03.001

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  39 in total

1.  Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma.

Authors:  N E El-Bassiouni; M M F Nosseir; M E Madkour; M M K Zoheiry; I W Bekheit; R A Ibrahim; I M Ibrahim; A E El Bassiouny
Journal:  Mol Biol Rep       Date:  2012-02-09       Impact factor: 2.316

Review 2.  Signal molecule-mediated hepatic cell communication during liver regeneration.

Authors:  Zhen-Yu Zheng; Shun-Yan Weng; Yan Yu
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

Review 3.  Endoplasmic reticulum stress is the crossroads of autophagy, inflammation, and apoptosis signaling pathways and participates in liver fibrosis.

Authors:  Xiaohui Li; Yarui Wang; Huan Wang; Cheng Huang; Yan Huang; Jun Li
Journal:  Inflamm Res       Date:  2014-10-07       Impact factor: 4.575

4.  Ca²⁺/calmodulin-dependent protein kinase II mediates platelet-derived growth factor-induced human hepatic stellate cell proliferation.

Authors:  An Ping; Tian Yihao; Dai Jingxing; Chen Minkai; Luo Hesheng
Journal:  Dig Dis Sci       Date:  2012-01-04       Impact factor: 3.199

5.  Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients.

Authors:  Bang-Bin Chen; Chao-Yu Hsu; Chih-Wei Yu; Shwu-Yuan Wei; Jia-Horng Kao; Hsuan-Shu Lee; Tiffany Ting-Fang Shih
Journal:  Eur Radiol       Date:  2011-08-31       Impact factor: 5.315

Review 6.  Gaining New Biological and Therapeutic Applications into the Liver with 3D In Vitro Liver Models.

Authors:  Sang Woo Lee; Da Jung Jung; Gi Seok Jeong
Journal:  Tissue Eng Regen Med       Date:  2020-03-23       Impact factor: 4.169

7.  Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention.

Authors:  Valerio Nobili; Anna Alisi; Massimiliano Raponi
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

Review 8.  Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives.

Authors:  Young Woo Eom; Gaeun Kim; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

9.  Experimental model in rats for study on transmission dynamics and evaluation of Clonorchis sinensis infection immunologically, morphologically, and pathologically.

Authors:  Xiaoyun Wang; Chi Liang; Wenjun Chen; Yongxiu Fan; Xuchu Hu; Jin Xu; Xinbing Yu
Journal:  Parasitol Res       Date:  2009-09-16       Impact factor: 2.289

10.  Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.

Authors:  Kim M Lonergan; Raj Chari; Bradley P Coe; Ian M Wilson; Ming-Sound Tsao; Raymond T Ng; Calum Macaulay; Stephen Lam; Wan L Lam
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.